Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National HealthCare Corporation’s filings rarely stop at numbers—they reveal how Medicare rate shifts, facility occupancy, and labor costs shape one of America’s largest post-acute care networks. If you have ever asked, “How do I track National HealthCare Corporation insider trading Form 4 transactions?” or searched for a “National HealthCare Corporation quarterly earnings report 10-Q filing,” this page brings every disclosure together—with context that matters.
Stock Titan’s AI reviews each 10-K, 10-Q, 8-K, proxy, and Form 4 within seconds of its EDGAR release. Our summaries turn intricate reimbursement footnotes into plain language, so understanding National HealthCare Corporation SEC documents with AI becomes straightforward. Need real-time alerts? We surface each National HealthCare Corporation Form 4 insider transactions real-time alongside concise commentary on buying or selling trends.
Here is what you will uncover:
- Annual report 10-K simplified: drill into facility occupancy, CMS revenue exposure, and lease commitments without scanning 300 pages.
- Quarterly earnings report filing analysis: compare therapy hours, wage inflation, and cash flow quarter over quarter.
- 8-K material events explained: instant clarity on acquisitions, rate updates, or pandemic-related guidance changes.
- Executive stock transactions Form 4: see whether leadership is accumulating or trimming shares.
- Proxy statement executive compensation: evaluate pay-for-performance metrics tied to occupancy and quality ratings.
Whether you monitor dividend sustainability or compliance risk, our platform keeps National HealthCare Corporation SEC filings explained simply. Save research hours, spot trends earlier, and make decisions with confidence.
BlackRock, Inc. filed a Schedule 13G/A (Amendment No. 7) disclosing beneficial ownership of 1,800,345 shares of National Healthcare Corp (NHC) common stock, representing 11.6% of the class as of the event date 09/30/2025.
BlackRock reports sole voting power over 1,770,601 shares and sole dispositive power over 1,800,345 shares. The filing certifies the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. Item 6 notes various persons have rights to dividends or sale proceeds from these securities, and no single person’s interest exceeds five percent of total outstanding common shares.
National Healthcare Corporation (NHC) disclosed that R. Michael Ussery, its President and Chief Operating Officer, informed the company on September 23, 2025 that he will retire effective December 31, 2025. Mr. Ussery has been with NHC since 1980 and has held roles including Senior Vice President-Operations, Senior Vice President-Central Region, Regional Vice President and multiple facility Administrator positions; he was named Administrator of the Year in 1989. He became Chief Operating Officer on January 1, 2009 and was appointed President on January 1, 2017, and will continue serving in both roles through his retirement. The company furnished a press release dated September 26, 2025 as Exhibit 99.1.
Robert G. Adams, a director of National HealthCare Corp (NHC), exercised options and acquired shares on 09/19/2025. He exercised 4,500 options from a 2021 grant at an exercise price of $71.64, resulting in the acquisition of 4,500 shares reported as an acquisition at $71.64 per share.
The filing shows Mr. Adams beneficially owns 13,579 shares following the transaction through a trust and holds indirect interests through a partnership position of 430,341 shares as general partner. The report also lists outstanding options granted in 2022, 2023, 2024 and 2025, each for 7,500 shares, with varying exercise prices and expiration dates.
National HealthCare Corporation's tenant subsidiary has been notified by its landlord, National Health Investors, Inc., of alleged non-compliance with four non-monetary provisions of a Master Lease covering 35 facilities. The landlord's September 8, 2025 letter asserts a default and invoked the lease cure provisions, giving the tenant thirty days to cure or risk an Event of Default. The tenant disputes that the alleged matters constitute defaults, says it has proceeded with reasonable diligence to address any issues, and is negotiating with the landlord. The Master Lease currently runs through December 31, 2026, with two five-year renewal options and a right of first refusal to purchase leased properties; termination that removes renewal rights could have a material adverse effect on NHC's financial condition.
Stephen Flatt, CEO and director of National Healthcare Corp. (NHC), reported multiple equity transactions on 08/22/2025. He exercised stock options and acquired 4,000 shares in two option exercises at strike prices of $53.94 and $94.10, and the filings show withholding of 3,146 shares to cover exercise costs and taxes at an effective price of $114.82 per share. After these transactions, Flatt beneficially owns between 59,393 and 61,393 common shares depending on the line item referenced. The exercises relate to grants from the 2020 Omnibus Equity Incentive Plan dated March 8, 2023 and March 5, 2024.
J. Paul Abernathy, a director of National Healthcare Corp. (NHC), reported exercising stock options and a related share withholding on August 13, 2025. He exercised options granted May 6, 2021, resulting in the acquisition of 4,010 shares at an exercise price implied by the filing of $71.64 per share. Simultaneously, 2,639 shares were withheld by the company to satisfy the exercise price, leaving Mr. Abernathy with 39,033 shares beneficially owned after the transactions. The filing lists outstanding option grants from 2022, 2023, 2024 and 2025, each covering 7,500 options with exercise prices from $69.19 to $96.03 and standard exercisability/expiration schedules.
Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp. (NHC), exercised stock options and reported related share withholding. On 08/13/2025 Mr. McCreary exercised 4,000 options with an exercise price of $53.94, resulting in 4,000 shares acquired. To cover the exercise price and withholding taxes, the company withheld 2,737 shares at an implied price of $108.82. After these transactions, Mr. McCreary beneficially owned 9,716 shares of NHC common stock.
The exercised options were part of a grant from the 2020 Omnibus Equity Incentive Plan issued on 03/08/2023 and are exempt from Section 16(b) under Rule 16b-3(d). The Form 4 was signed 08/15/2025 and reports both non-derivative and derivative holdings, including existing options exercisable through 2030.
National HealthCare Corporation (NHC) filed a Form 8-K dated 8 Aug 2025 reporting Item 8.01 – Other Events. The filing states that on 7 Aug 2025 the company issued a press release announcing its quarterly common-stock dividend. The press release is furnished as Exhibit 99.1 and is incorporated by reference. No dividend amount, record date, or payment date is disclosed within the 8-K itself, and no additional financial data or material transactions are presented.
FAQ
What is the current stock price of National Health (NHC)?
What is the market cap of National Health (NHC)?
